About the Product

Description


Decrazine 50 Tablet containing Diethylcarbamazine is used for the treatment and prevention of parasitic infections such as filariasis. It helps eliminate parasites from the body and supports infection control.

Diethylcarbamazine works by affecting the metabolism of parasites, thereby helping the immune system clear the infection effectively.

The tablet is widely used in anti-parasitic therapy and infectious disease management programs, leading to consistent demand in clinical practice.

With increasing focus on parasitic infection control and public health programs, this product offers strong business potential for retailers and distributors. Its established therapeutic role, public health relevance, and steady demand make it a reliable product for growth in the anti-infective segment.

Some patients may experience fever, headache, dizziness, nausea, vomiting, itching, or allergic reactions due to parasite breakdown. Rarely, severe hypersensitivity reactions may occur.

Decrazine 50 Tablet is indicated for filariasis (elephantiasis), loiasis, tropical eosinophilia, and other filarial worm infections. It helps eliminate parasites, reduce swelling, and control infection-related complications.

This medicine should be used under strict medical supervision. Patients may require supportive therapy during treatment due to parasite die-off reactions. Use cautiously in patients with kidney or liver disorders.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Decrazine 50 Tablet in the PCD pharma franchise market?

Decrazine 50 Tablet, containing Diethylcarbamazine 50mg, has strong demand in the anti-parasitic and infectious disease segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on tropical disease and general medicine portfolios.

Why should medical distributors include Decrazine 50 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for anti-filarial therapies used in the management of filariasis, eosinophilia, and parasitic worm infections. Decrazine 50 Tablet helps strengthen a comprehensive anti-infective and tropical disease care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Decrazine 50 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Decrazine 50 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Decrazine 50 Tablet distribution?

Wholesalers and medical agencies benefit from steady prescription demand, strong market presence in anti-parasitic therapy, reliable supply chain support, and good margins when partnering for Decrazine 50 Tablet distribution.

How can I become a distributor or franchise partner for Decrazine 50 Tablet?

Medical distributors, stockists, and wholesalers interested in Decrazine 50 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.